Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy amo

• 作 者: Yu-Qi LIU Dan-Dan LI Meng CHAI
• 机 构: DepartmentofCardiology,DepartmentofCardiology,DepartmentofCardiology,DepartmentofCardiology,Departme
• 出 处: 老年心脏病学杂志:英文版
• 发表日期: 2021年4期
• 关键词: LDL RWE-PCSK study Real world effectiveness of PCSK-9 inhibitors combin
• 基金项目: supported by the China Cardiovascular Health Alliance-Advanced Fund (2019CCA-ACCESS-054),the Beijing Lisheng Cardiovascular Health Foundation Pilot Fund Key Projects

BACKGROUND The efficacy and safety of proprotein convertase subtilisin/kexin type 9(PCSK-9) inhibitors were confirmed by several clinical trials, but its effectiveness in routine clinical practice in China has not been evaluated. This study aims to descri